{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:59:17Z","timestamp":1782979157522,"version":"3.54.5"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/md.0000000000003573","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T15:07:09Z","timestamp":1464275229000},"page":"e3573","source":"Crossref","is-referenced-by-count":40,"title":["Recommended Initial Antimicrobial Therapy for Emphysematous Pyelonephritis"],"prefix":"10.1097","volume":"95","author":[{"given":"Yu-Chuan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Juin","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Hung","family":"Pong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Shiau","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210226","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0022-5347(17)50309-2","article-title":"Emphysematous pyelonephritis","volume":"131","author":"Michaeli","year":"1984","journal-title":"J Urol"},{"key":"R2-13-20210226","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1464-410X.1995.tb07237.x","article-title":"Emphysematous pyelonephritis in diabetic patients","volume":"75","author":"Pontin","year":"1995","journal-title":"Brit J Urol"},{"key":"R3-13-20210226","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-5347(17)65043-2","article-title":"Emphysematous pyelonephritis","volume":"87","author":"Schultz","year":"1962","journal-title":"J Urol"},{"key":"R4-13-20210226","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.juro.2008.01.019","article-title":"Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review","volume":"179","author":"Somani","year":"2008","journal-title":"J Urol"},{"key":"R5-13-20210226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00007611-198601000-00013","article-title":"Emphysematous pyelonephritis: diagnosis and treatment","volume":"79","author":"Klein","year":"1986","journal-title":"South Med J"},{"key":"R6-13-20210226","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrurol.2009.51","article-title":"Current management of emphysematous pyelonephritis","volume":"6","author":"Pontin","year":"2009","journal-title":"Nat Rev Urol"},{"key":"R7-13-20210226","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1464-410X.2010.09660.x","article-title":"Emphysematous pyelonephritis","volume":"107","author":"Ubee","year":"2011","journal-title":"BJU Int"},{"key":"R8-13-20210226","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archinte.160.6.797","article-title":"Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis","volume":"160","author":"Huang","year":"2000","journal-title":"Arch Intern Med"},{"key":"R9-13-20210226","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0002-9343(86)90518-8","article-title":"Escherichia coli bacteremia in cancer patients","volume":"81","author":"Bodey","year":"1986","journal-title":"Am J Med"},{"key":"R10-13-20210226","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3810\/pgm.2010.11.2217","article-title":"Management of complicated urinary tract infections in the era of antimicrobial resistance","volume":"122","author":"Bader","year":"2010","journal-title":"Postgrad Med"},{"key":"R11-13-20210226","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/520427","article-title":"Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA)","volume":"29","author":"Warren","year":"1999","journal-title":"Clin Infect Dis"},{"key":"R12-13-20210226","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s15010-005-5045-9","article-title":"Risk factors for colonization with third-generation cephalosporin-resistant enterobacteriaceae","volume":"33","author":"Wendt","year":"2005","journal-title":"Infection"},{"key":"R13-13-20210226","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jhep.2011.11.010","article-title":"Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis","volume":"56","author":"Ariza","year":"2012","journal-title":"J Hepatol"},{"key":"R14-13-20210226","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"R15-13-20210226","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R16-13-20210226","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ijantimicag.2007.07.033","article-title":"European and Asian guidelines on management and prevention of catheter-associated urinary tract infections","volume":"31","author":"Tenke","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"R17-13-20210226","first-page":"185","article-title":"Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection","volume":"37","author":"Lau","year":"2004","journal-title":"J Microbiol Immunol Infect"},{"key":"R18-13-20210226","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jmii.2011.01.015","article-title":"Consensus statement on the role of fluoroquinolones in the management of urinary tract infections","volume":"44","author":"Hsueh","year":"2011","journal-title":"J Microbiol Immunol Infect"},{"key":"R19-13-20210226","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1086\/592250","article-title":"Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis","volume":"47","author":"Talan","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R20-13-20210226","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ajem.2010.09.030","article-title":"High rates of quinolone resistance among urinary tract infections in the ED","volume":"30","author":"Khawcharoenporn","year":"2012","journal-title":"Am J Emerg Med"},{"key":"R21-13-20210226","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/j.amjmed.2009.08.024","article-title":"Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates","volume":"123","author":"Caron","year":"2010","journal-title":"Am J Med"},{"key":"R22-13-20210226","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/jac\/dkq465","article-title":"Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection","volume":"66","author":"van der Starre","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"R23-13-20210226","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1464-410X.2009.08930.x","article-title":"Predictive factors for mortality and need for nephrectomy in patients with emphysematous pyelonephritis","volume":"105","author":"Kapoor","year":"2010","journal-title":"BJU Int"},{"key":"R24-13-20210226","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.urology.2014.02.010","article-title":"Emphysematous pyelonephritis: multicenter clinical and therapeutic experience in Mexico","volume":"83","author":"Olvera-Posada","year":"2014","journal-title":"Urology"},{"key":"R25-13-20210226","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11255-009-9552-y","article-title":"Retrospective analysis of clinical profile prognostic factors and outcomes of 19 patients of emphysematous pyelonephritis","volume":"41","author":"Khaira","year":"2009","journal-title":"Int Urol Nephrol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000003573","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:23:51Z","timestamp":1620959031000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201605240-00013"}},"subtitle":["51 Cases and 14-Year-Experience of a Tertiary Referral Center"],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":25,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003573","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}